140 related articles for article (PubMed ID: 9184712)
21. [Thrombocytopenia following a re-introduction of rifampicin in a daily treatment. Apropos of a case].
Beji M; Louzir B; Ben Rhomdane N; Zouari M; Mtimet B; Daghfous J
Tunis Med; 1995 May; 73(5):201-3. PubMed ID: 9507284
[No Abstract] [Full Text] [Related]
22. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
Dekker TG; Lötter AP
Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
[No Abstract] [Full Text] [Related]
23. Ethambutol-induced pulmonary infiltrates with fever and skin rash: a case report.
Chien HP; Huang ST; Yu MC; Wu IH; Lin TP
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jun; 61(6):371-4. PubMed ID: 9684516
[TBL] [Abstract][Full Text] [Related]
24. [Fixed drug eruption after taking ethambutol].
Bakayoko AS; Kaloga M; Kamagate M; Kone Z; Daix AT; Ohui E; Gbery I; Domoua K
Rev Mal Respir; 2015 Jan; 32(1):48-51. PubMed ID: 25618204
[TBL] [Abstract][Full Text] [Related]
25. [Fever and thin-walled cavitary lung lesions].
Ramos A; Daza R; Alvarez-Espejo T; Guzmán MF
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):363-4. PubMed ID: 19419797
[No Abstract] [Full Text] [Related]
26. Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis.
Guo N; Marra F; Fitzgerald JM; Elwood RK; Marra CA
Eur Respir J; 2010 Jul; 36(1):206-8. PubMed ID: 20595167
[No Abstract] [Full Text] [Related]
27. [Recommendations for the therapy of tuberculosis. (Position: December, 1988)].
Merkel S; Fischer P; Weinecke W
Z Erkr Atmungsorgane; 1989; 173(1):87-96. PubMed ID: 2800620
[No Abstract] [Full Text] [Related]
28. Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
Lee BH; Koh WJ; Choi MS; Suh GY; Chung MP; Kim H; Kwon OJ
Chest; 2005 Apr; 127(4):1304-11. PubMed ID: 15821209
[TBL] [Abstract][Full Text] [Related]
29. Antituberculous therapy-induced toxicity.
Bharat A; Vedkumar M; Subhash HS; Abraham OC; Mathai D
J Assoc Physicians India; 2003 May; 51():522-4. PubMed ID: 12974441
[TBL] [Abstract][Full Text] [Related]
30. Antituberculous therapy and acute liver failure.
McKeon J; Patel AM
Lancet; 1995 May; 345(8958):1170-1. PubMed ID: 7723556
[No Abstract] [Full Text] [Related]
31. A 32-year-old man with tuberculosis, fever, and rash.
Story RE; Ditto AM
Ann Allergy Asthma Immunol; 2004 May; 92(5):495-9. PubMed ID: 15191016
[No Abstract] [Full Text] [Related]
32. Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
Jeong I; Park JS; Cho YJ; Yoon HI; Song J; Lee CT; Lee JH
J Korean Med Sci; 2015 Feb; 30(2):167-72. PubMed ID: 25653488
[TBL] [Abstract][Full Text] [Related]
33. Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
Schreiber J; Zissel G; Greinert U; Schlaak M; Müller-Quernheim J
Eur J Med Res; 1999 Feb; 4(2):67-71. PubMed ID: 10066642
[TBL] [Abstract][Full Text] [Related]
34. [Therapeutic approach in a case of allergic reaction to antituberculosis drugs -- a case report].
Costin M; Tesloianu A; Mihăescu T; Butnaru E
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):487-9. PubMed ID: 23077942
[TBL] [Abstract][Full Text] [Related]
35. [Cutaneous reaction after pyrazinamide initiation].
Mulliez P; Mbassi Fouda FL; Roy Saint-Georges F
Med Mal Infect; 2011 Sep; 41(9):499-500. PubMed ID: 21458177
[No Abstract] [Full Text] [Related]
36. Acute liver failure in a pediatric patient with disseminated tuberculosis.
Whitney J; Hurwitz M; Mojtahed A; Hwang C; Gallo A
Dig Dis Sci; 2011 Oct; 56(10):2780-3. PubMed ID: 21695402
[No Abstract] [Full Text] [Related]
37. Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.
Reves R; Heilig CM; Tapy JM; Bozeman L; Kyle RP; Hamilton CD; Bock N; Narita M; Wing D; Hershfield E; Goldberg SV;
Int J Tuberc Lung Dis; 2014 May; 18(5):571-80. PubMed ID: 24903795
[TBL] [Abstract][Full Text] [Related]
38. A case of isoniazid-induced liver injury diagnosed by use of the DLST, and successful reintroduction of isoniazid for pleural tuberculosis.
Ikegame S; Wakamatsu K; Fujita M; Nakanishi Y; Kajiki A
J Infect Chemother; 2011 Aug; 17(4):530-3. PubMed ID: 21188445
[TBL] [Abstract][Full Text] [Related]
39. Ultrashort-course chemotherapy for culture-negative pulmonary tuberculosis--a qualified success.
Cowie RL; Langton ME; Escreet BC
S Afr Med J; 1985 Dec; 68(12):879-80. PubMed ID: 4071345
[TBL] [Abstract][Full Text] [Related]
40. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
